These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33049658)

  • 21. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.
    Zhang XY; Liang J; Chen DC; Xiu MH; Yang FD; Kosten TA; Kosten TR
    Psychopharmacology (Berl); 2012 Jul; 222(2):277-84. PubMed ID: 22274000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between BDNF levels and risperidone-induced weight gain is dependent on the BDNF Val66Met polymorphism in antipsychotic-naive first episode schizophrenia patients: a 12-week prospective study.
    Liu J; Wang P; Sun L; Guan X; Xiu M; Zhang X
    Transl Psychiatry; 2021 Sep; 11(1):458. PubMed ID: 34482368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Risperidone and Paliperidone on Brain-Derived Neurotrophic Factor and N400 in First-Episode Schizophrenia.
    Wu RQ; Lin CG; Zhang W; Lin XD; Chen XS; Chen C; Zhang LJ; Huang ZY; Chen GD; Xu DL; Lin ZG; Zhang MD
    Chin Med J (Engl); 2018 Oct; 131(19):2297-2301. PubMed ID: 30246715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
    Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
    World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
    Riedel M; Spellmann I; Strassnig M; Douhet A; Dehning S; Opgen-Rhein M; Valdevit R; Engel RR; Kleindienst N; Müller N; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):360-70. PubMed ID: 17629731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The microRNA-195 - BDNF pathway and cognitive deficits in schizophrenia patients with minimal antipsychotic medication exposure.
    Pan S; Feng W; Li Y; Huang J; Chen S; Cui Y; Tian B; Tan S; Wang Z; Yao S; Chiappelli J; Kochunov P; Chen S; Yang F; Li CR; Tian L; Tan Y; Elliot Hong L
    Transl Psychiatry; 2021 Feb; 11(1):117. PubMed ID: 33558459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive impairment in first-episode drug-naïve patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor.
    Xiao W; Ye F; Liu C; Tang X; Li J; Dong H; Sha W; Zhang X
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():163-168. PubMed ID: 28342945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia.
    Li J; Ye F; Xiao W; Tang X; Sha W; Zhang X; Wang J
    Eur Psychiatry; 2016 Aug; 36():23-8. PubMed ID: 27311104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burnout and cognitive impairment: Associated with serum BDNF in a Chinese Han population.
    He SC; Zhang YY; Zhan JY; Wang C; Du XD; Yin GZ; Cao B; Ning YP; Soares JC; Zhang XY
    Psychoneuroendocrinology; 2017 Mar; 77():236-243. PubMed ID: 28119229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
    Goldberg TE; Goldman RS; Burdick KE; Malhotra AK; Lencz T; Patel RC; Woerner MG; Schooler NR; Kane JM; Robinson DG
    Arch Gen Psychiatry; 2007 Oct; 64(10):1115-22. PubMed ID: 17909123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cognitive effectiveness of risperidone and olanzapine in first-episode schizophrenia].
    Zhao J; Zhang Y; Chao YY; Ma J; Yang YF; Zhao JY; Du YH; Li WW; Song XQ; Lü LX
    Zhonghua Yi Xue Za Zhi; 2016 Oct; 96(37):2960-2964. PubMed ID: 27760654
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of antipsychotics on the serum BDNF levels in schizophrenia.
    Chen CC; Huang TL
    Psychiatry Res; 2011 Oct; 189(3):327-30. PubMed ID: 21320726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction.
    Tang X; Zhou C; Gao J; Duan W; Yu M; Xiao W; Zhang X; Dong H; Wang X; Zhang X
    BMC Psychiatry; 2019 Aug; 19(1):254. PubMed ID: 31420036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
    Harvey PD; Rabinowitz J; Eerdekens M; Davidson M
    Am J Psychiatry; 2005 Oct; 162(10):1888-95. PubMed ID: 16199835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients.
    Yoshimura R; Hori H; Sugita A; Ueda N; Kakihara S; Umene W; Nakano Y; Shinkai K; Mitoma M; Ohta M; Shinkai T; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1072-7. PubMed ID: 17459549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of different antipsychotic drugs on cognitive function in patients with chronic schizophrenia.
    Dong R; Yuan L; Yang Y; Du XD; Jia Q; Dillon BA; Yu L; Zhang XY
    Hum Psychopharmacol; 2020 Nov; 35(6):1-8. PubMed ID: 32945023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia.
    Molina V; Taboada D; Aragüés M; Hernández JA; Sanz-Fuentenebro J
    Schizophr Res; 2014 Sep; 158(1-3):223-9. PubMed ID: 25088730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage migration inhibitory factor as a potential novel biomarker for cognitive function in patients with first-episode schizophrenia.
    Yu JJ; Zhao Q; Li HN; Song JQ; Chen DC
    Aust N Z J Psychiatry; 2022 Mar; 56(3):292-300. PubMed ID: 33985351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low BDNF is associated with cognitive impairments in patients with Parkinson's disease.
    Wang Y; Liu H; Zhang BS; Soares JC; Zhang XY
    Parkinsonism Relat Disord; 2016 Aug; 29():66-71. PubMed ID: 27245919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.